Somany Ceramics Q1 FY27 Earnings Call — Analysis (NSE: SOMANYCERA)
Somany Q1FY27 volume was constrained by the Morbi shutdown but EBITDA margin jumped to 11.6% on capacity utilisation and JV turnaround
Result quality: strong — Margin expansion. Management sentiment: optimistic.
The take
Q1FY27 Revenue ₹749.56 Cr ( +24% YoY ) . New guidance — FY27 revenue potential from existing… ≈₹3,700 Cr plus ₹300 Cr . New story: Capacity utilisation-led margin expansion .
Results
Revenue ₹749.56 Cr +24% YoY; volume +3% YoY; EBITDA margin 11.6% (+360 bps YoY); JV swung from -₹10 Cr to +₹3 Cr
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue | ₹749.56 Cr | +24% | yoy · Q1FY27 · Value growth as stated by management |
| Volume growth | 3% | +3% | yoy · Q1FY27 · Reported volume growth; impacted by Morbi shutdown in April |
| EBITDA margin | 11.6% | +360 bps | yoy · Q1FY27 · Management stated margins up 3.6 percentage points |
| Standalone capacity utilisation | 83% | +11 percentage points | yoy · Q1FY27 · Q1FY26: 72% |
| JV net profit | ₹3 Cr | yoy · Q1FY27 · Q1FY26: -₹10 Cr | |
| Net profit | ₹34.23 Cr | +242.72% | yoy · Q1FY27 · Company fundamentals data |
| Working capital days | 12 days | qoq · Q1FY27 · Down from 17 days |
Guidance
Management guided FY27 volume growth in mid-single digits, expects to sustain 11%-plus EBITDA margins with a target of 12%+, and plans ~₹275 Cr capex including a 9+ million sqm South plant
What management committed to
- Somany Ceramics expects FY27 volume growth in mid-single digits — mid-single digits, FY27
- Somany Ceramics will maintain the EBITDA margin delivered in Q1FY27 (11.6%) and is trying to better it — 11.6%, FY27
- Somany Ceramics targets EBITDA margin of 12% and more — 12% and more, going forward
- The JV business will be in net profit in FY27 after a loss of about ₹24-25 Cr in FY26, producing a swing of more than ₹30 Cr — net profit in FY27; swing >₹30 Cr, FY27
- The 9-plus million square metre [South plant] will be operational within 12 to 15 months and has potential revenue of about ₹350 crore — 9-plus million sq metre; potential revenue ~₹350 Cr, Q4FY28
- Somany Ceramics will add 4-5 million square metres of capacity via balancing equipment at [Bahadurgarh, Gujarat, Morbi and South existing lines]; this will be ready from mid-Q3FY27 and complete in Q4FY27 and will add value-added mix — 4-5 million sqm, Q4FY27
- Capex outlay from now to FY27 end is approximately ₹275 crore, including ₹220 crore for the [South greenfield tile plant], with 65-70% funded by internal accruals and the small JV loan having no Somany corporate guarantee — ~₹275 Cr; 65-70% internal accruals, FY27
- At current capacity and today's prices, Somany Ceramics can generate maximum revenue of approximately ₹3,700 Cr (give or take ₹50 Cr), with the debottlenecking by year-end likely adding about ₹300 Cr more — ≈₹3,700 Cr plus ₹300 Cr, FY27
- Project segment contribution will go up by about 3% to 4% in totality from current mix of ~7-8% retail and ~10-11% government — up by about 3% to 4%, FY27
- Somany Max loss in FY27 will be controlled to ₹10 crore or less — ₹10 Cr loss or less, FY27
- Capacity utilisation in Q2FY27 will be slightly better than the 83% standalone level reported in Q1FY27 — slightly better than 83%, Q2FY27
- Sales volume lost in Q1FY27 due to Morbi disruption will be made up very handsomely in Q2FY27 — Q1 missed sales made up, Q2FY27
Key themes
Margin resilience and capacity expansion
How the narrative shifted
- Capacity utilisation-led margin expansion: Management attributes Q1 EBITDA margin improvement to own plants at 83% utilisation and JV operating leverage, not pricing
- JV turnaround and P&L swing: JV losses of last year are reversing; management expects net profit and >₹30 Cr swing
- Morbi supply disruption and normalisation: April volume was hit by Morbi shutdown; Morbi restarted 100% on costlier gas, with a portion permanently out
- Gas price volatility and pass-through: Gas prices rose monthly and were passed through via 16-18% price hikes; if gas falls, benefits will be passed back
- Capacity expansion and value-added mix: New South greenfield and debottlenecking across existing plants will add volume and improve mix
- Conservative volume guidance / credibility repair: Management under-promises after past volume disappointments; prioritises defending margin and delivering realistic mid-single-digit growth
- Export weakness from geopolitical/freight: Morbi exports are down 50-60% from peak and expected to stay weak until freight settles
- Working capital discipline: Working capital days reduced from 17 to 12, with receivables/inventory/creditor days healthy
Operational commentary
- Announced 9+ million sqm South greenfield tile plant; capex ~₹220 Cr, operational in 12-15 months, potential revenue ~₹350 Cr
- Additional 4-5 million sqm capacity via balancing/de-bottlenecking across Bahadurgarh, Gujarat, Morbi and South to be ready mid-Q3FY27 and complete Q4FY27; expected to improve value-added mix
- Standalone capacity utilisation rose to 83% from 72% YoY; management expects Q2 utilisation to be slightly better
- JVs swung to ₹3 Cr profit in Q1FY27 from ₹10 Cr loss in Q1FY26; management expects FY27 JV net profit and >₹30 Cr swing
- Morbi restart normalised to 100% from May-end; 15-17% of Morbi capacity is permanently out; Morbi exports down 50-60% from peak on geopolitical/freight issues
- Working capital improved: days down from 17 to 12; receivables, inventory and creditor days healthy; stocks reduced significantly
- Construction chemical capacity expanded in South and a large North plant commenced last month; benefits expected partly in Q2FY27 and mostly next quarter
- Project segment currently ~7-8% retail and ~10-11% government; total project mix expected to go up 3-4%
- Bathware profitability about 1% above normal tile margins; Somany Max loss reduced from ₹7 Cr to ~₹1+ Cr in Q1
- Gas price hikes of 16-18% fully passed on; blended natural gas cost ~₹68 in North, mid-70s in South/Morbi
Analyst Q&A
Q. What drove the strong Q1 margin improvement and how structural is it through Q2?
Capacity utilisation in standalone improved from 72% to 83% YoY, and JVs swung from a ₹10 Cr loss to ₹3 Cr profit; management is very confident of maintaining and only bettering this margin.
Q. What is the July demand trend and current Morbi status?
April was slow due to material supply, not demand; Morbi has been open since May and at 100% capacity from May-end, though 15-17% of Morbi capacity will never restart. July demand was tough due to rains but sales were pushed.
Q. Should the company consider a share buyback given the valuation discount and negative 5-year stock CAGR?
Thank you for your suggestion.
Q. Can margins sustain after Morbi normalises and exports weaken?
Margin improvement came from operational efficiency and 100% own-plant utilisation plus reduced JV losses, not pricing; therefore sustainment does not depend on Morbi pricing.
Q. Why guide only mid-single-digit volume growth when the leader and smaller peers are growing faster?
The leader had higher in-house PVT production; smaller players' growth is not sustainable; the company is cautious after past guidance misses and only wants to make promises it will deliver.
Q. Why is Somany's margin still far below the industry leader's 18-19%?
There are many areas of discussion; maybe we take it offline.
Research and educational content only. Not investment advice.